Physician profile
Kylee V Stanley
NPI 1619236379
$1,959.24
in general payments reported to CMS, 2019-2025
36 companies · $634 in 2025
The $634 reported for 2025 was more than what 78% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $102 · 2020: $37.36 · 2021: $192 · 2022: $465 · 2023: $251 · 2024: $278 · 2025: $634.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,162.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $382.49 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $189.77 | 2022-2025 | |
| Amgen INC. | $168.23 | 2019-2025 | Prolia, Evenity, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $122.24 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Lilly USA, LLC | $116.71 | 2021-2025 | Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals Lp | $108.37 | 2022-2025 | Airsupra, Farxiga |
| Janssen Pharmaceuticals, INC | $98.22 | 2022-2023 | Xarelto |
| Abbott Laboratories | $62.53 | 2021-2023 | Freestyle Libre 3 |
| Abbvie INC. | $52.96 | 2024-2025 | |
| Biogen, INC. | $51.29 | 2021-2022 | |
| Glaxosmithkline, LLC. | $50.48 | 2019-2023 | Trelegy Ellipta, Arexvy, Shingrix |
| Bayer Healthcare Pharmaceuticals INC. | $46.90 | 2021-2025 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $39.60 | 2022 | |
| Seqirus USA INC | $37.53 | 2022-2024 | Fluad |
| Abiomed | $36.25 | 2025 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $35.47 | 2025 | Attruby |
| Philips North America LLC | $34.86 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $33.66 | 2024-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $20.60 | 2025 | |
| United Therapeutics Corporation | $20.01 | 2025 | |
| Therapeuticsmd, INC. | $19.92 | 2019 | |
| Impel Pharmaceuticals INC. | $19.77 | 2022 | |
| Axsome Therapeutics, INC. | $18.59 | 2025 | Auvelity |
| Harmony Biosciences LLC | $17.90 | 2025 | |
| Aimmune Therapeutics, INC. | $17.32 | 2025 | Zenpep |
| Organon LLC | $16.65 | 2022 | |
| Kyowa Kirin, INC. | $16.51 | 2023 | Crysvita |
| Boston Scientific Corporation | $16.34 | 2025 | Intracept |
| Mannkind Corporation | $16.29 | 2025 | |
| Irhythm Technologies, INC. | $15.73 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.48 | 2022 | |
| Scpharmaceuticals INC. | $14.32 | 2025 | |
| Sanofi Pasteur INC. | $12.64 | 2020 | |
| Acadia Pharmaceuticals INC | $12.22 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $11.44 | 2021 | |
| Daiichi Sankyo INC. | $10.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kylee Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.